{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:49:28Z","timestamp":1790714968761,"version":"4.1.0"},"reference-count":42,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/501100001238","name":"Society of Hospital Pharmacists of Australia","doi-asserted-by":"publisher","award":["MSD1301"],"award-info":[{"award-number":["MSD1301"]}],"id":[{"id":"10.13039\/501100001238","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Microbiol Spectr"],"published-print":{"date-parts":[[2022,6,29]]},"abstract":"<jats:p>\n                    Current guidelines recommend that aminoglycosides should be used in combination with \u03b2-lactam antibiotics as initial empirical therapy for serious infections, and otherwise, patients should receive \u03b2-lactam antibiotic monotherapy. Given the challenges associated with studying the clinical effect of different antibiotic strategies on patient outcomes, useful data for subsequent informed clinical testing can be obtained from\n                    <jats:italic>in vitro<\/jats:italic>\n                    models like the hollow-fiber infection model (HFIM).\n                  <\/jats:p>","DOI":"10.1128\/spectrum.00525-22","type":"journal-article","created":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T09:06:38Z","timestamp":1650445598000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":16,"title":["Evaluating Mono- and Combination Therapy of Meropenem and Amikacin against Pseudomonas aeruginosa Bacteremia in the Hollow-Fiber Infection Model"],"prefix":"10.1128","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7228-2834","authenticated-orcid":true,"given":"Minyon L.","family":"Avent","sequence":"first","affiliation":[{"name":"The University of Queensland, UQ Centre for Clinical Research, Herston, Queensland, Australia"},{"name":"Queensland Statewide Antimicrobial Stewardship Program, Royal Brisbane and Women\u2019s Hospital, Herston, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6173-9659","authenticated-orcid":true,"given":"Kate L.","family":"McCarthy","sequence":"additional","affiliation":[{"name":"The University of Queensland, UQ Centre for Clinical Research, Herston, Queensland, Australia"},{"name":"Department of Infectious Diseases, Royal Brisbane and Women\u2019s Hospital, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4061-2063","authenticated-orcid":true,"given":"Fekade B.","family":"Sime","sequence":"additional","affiliation":[{"name":"The University of Queensland, UQ Centre for Clinical Research, Herston, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saiyuri","family":"Naicker","sequence":"additional","affiliation":[{"name":"The University of Queensland, UQ Centre for Clinical Research, Herston, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7929-9812","authenticated-orcid":true,"given":"Aaron J.","family":"Heffernan","sequence":"additional","affiliation":[{"name":"The University of Queensland, UQ Centre for Clinical Research, Herston, Queensland, Australia"},{"name":"School of Medicine, Griffith University, Southport, Queensland, Australia"},{"name":"Department of Pharmacy, Royal Brisbane and Women\u2019s Hospital, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven C.","family":"Wallis","sequence":"additional","affiliation":[{"name":"The University of Queensland, UQ Centre for Clinical Research, Herston, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2079-4437","authenticated-orcid":true,"given":"David L.","family":"Paterson","sequence":"additional","affiliation":[{"name":"The University of Queensland, UQ Centre for Clinical Research, Herston, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6218-435X","authenticated-orcid":true,"given":"Jason A.","family":"Roberts","sequence":"additional","affiliation":[{"name":"The University of Queensland, UQ Centre for Clinical Research, Herston, Queensland, Australia"},{"name":"Department of Pharmacy, Royal Brisbane and Women\u2019s Hospital, Brisbane, Australia"},{"name":"Department of Intensive Care Medicine, Royal Brisbane and Women\u2019s Hospital, Brisbane, Australia"},{"name":"Division of Anaesthesiology, Critical Care Emergency and Pain Medicine, N\u00eemes University Hospital, University of Montpellier, N\u00eemes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02235-12"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.31.6.598"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.05041-11"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01365-09"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00338-07"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003038"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(02)00241-4"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2019.10.020"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccc.2010.11.006"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365548.2012.747694"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkm193"},{"key":"e_1_3_2_13_2","unstructured":"EUCAST. 2020. Guidance document on implementation and use of the revised aminogylocoside break points. https:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Guidance_documents\/Aminoglycoside_guidance_document_20200424.pdf."},{"key":"e_1_3_2_14_2","volume-title":"Applied pharmacokinetics and pharmacodynamics: principles of therapeutic drug monitoring.","author":"Burton ME","year":"2006","unstructured":"Burton ME, Shaw LM, Schentag JJ, Evans WE (ed). 2006. Applied pharmacokinetics and pharmacodynamics: principles of therapeutic drug monitoring. Lippincott, Williams & Wilkins, Philadelphia, PA."},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01485-12"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(14)70036-2"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkz437"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02307-18"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.2174\/138920111798808428"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0b013e328358afe5"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02642-16"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-019-00791-z"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01679-19"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2021.106344"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00722-17"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01680-08"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0205036"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv228"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu237"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01721-09"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu603"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00133-10"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx315"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.3947\/ic.2014.46.3.149"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30228-1"},{"key":"e_1_3_2_36_2","first-page":"305","volume-title":"Mandell, Douglas, and Bennett\u2019s principles and practice of infectious diseases","author":"Bennett JE","year":"2020","unstructured":"Bennett JE, Dolin R, Blaser MJ. 2020. Mandell, Douglas, and Bennett\u2019s principles and practice of infectious diseases, 9th ed, p 305\u2013317. Elsevier, Philadelphia, PA.","edition":"9"},{"key":"e_1_3_2_37_2","unstructured":"CLSI. 2014. Performance standards for antimicrobial susceptibility testing; 24th informational supplement. CLSI document M100-S24. CLSI Wayne PA."},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1469-0691.2003.00790.x"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.4172\/2167-1052.S1-007:S1"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/15.suppl_a.125"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-016-2053-x"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-199815050-00008"},{"key":"e_1_3_2_43_2","unstructured":"FDA. 2018. Bioanalytical method validation guidance for industry. US Food and Drug Administration Silver Spring MD."}],"container-title":["Microbiology Spectrum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.00525-22","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.00525-22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T09:47:11Z","timestamp":1656496031000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/spectrum.00525-22"}},"subtitle":[],"editor":[{"given":"Cezar M.","family":"Khursigara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,6,29]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6,29]]}},"alternative-id":["10.1128\/spectrum.00525-22"],"URL":"https:\/\/doi.org\/10.1128\/spectrum.00525-22","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.12.23.474080","asserted-by":"object"}]},"ISSN":["2165-0497"],"issn-type":[{"value":"2165-0497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,29]]},"assertion":[{"value":"2022-03-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-28","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00525-22"}}